FibroBiologics, Inc.
FBLG
$0.96
$0.033.23%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.90% | -65.01% | -37.82% | 48.08% | 6.24% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 58.88% | 546.67% | 5.67% | 157.34% | -13.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2,138.89% | -- | -- | -- | 0.00% |
| Total Current Assets | -68.85% | -55.38% | -36.08% | 56.37% | 4.54% |
|
|
|||||
| Total Current Assets | -68.85% | -55.38% | -36.08% | 56.37% | 4.54% |
| Net Property, Plant & Equipment | 42.21% | 45.33% | 52.18% | 53.18% | -15.26% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -48.03% | -41.51% | -16.48% | 56.05% | 0.24% |
|
|
|||||
| Total Accounts Payable | -40.01% | -64.96% | -9.33% | 49.09% | 74.08% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -95.79% | -- | 3,876.52% | 2,710.45% | 1,172.11% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 75.49% | 76.06% | 64.03% | 64.14% | 10.75% |
| Total Finance Division Other Current Liabilities | -98.16% | -76.52% | -91.24% | -94.31% | -95.60% |
| Total Other Current Liabilities | -98.16% | -76.52% | -91.24% | -94.31% | -95.60% |
| Total Current Liabilities | -77.73% | -86.18% | 0.67% | 8.21% | -41.29% |
|
|
|||||
| Total Current Liabilities | -77.73% | -86.18% | 0.67% | 8.21% | -41.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -95.79% | -- | 3,876.52% | 2,710.45% | 1,172.11% |
| Capital Leases | 74.45% | 73.17% | 79.81% | 78.49% | -32.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -63.22% | -74.74% | 11.47% | 15.47% | -40.53% |
|
|
|||||
| Common Stock & APIC | 44.19% | 57.69% | 45.20% | 55.77% | 47.94% |
| Retained Earnings | -46.14% | -52.50% | -57.07% | -41.43% | -23.36% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.64% | 125.08% | -95.43% | 136.03% | 160.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.64% | 125.08% | -95.43% | 136.03% | 160.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.64% | 125.08% | -95.43% | 136.03% | 160.83% |
|
|
|||||